Loading...
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies
The few therapeutic strategies for advance hepatocellular carcinoma (HCC) on poor knowledge of its biology. For several years, sorafenib, a tyrosine kinase inhibitors (TKI) inhibitor, has been the approved treatment option, to date, for advanced HCC patients. Its activity is the inhibition of the re...
Na minha lista:
| Udgivet i: | Medicina (Kaunas) |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6956203/ https://ncbi.nlm.nih.gov/pubmed/31766556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina55120754 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|